Fact CheckerSign in

NCT06806852Active, not recruitingPhase 1

A study to test whether treatment with BI 770371 in combination with pembrolizumab with or without cetuximab helps people with head and neck cancer compared with pembrolizumab alone

Source: EU CTIS (euclinicaltrials.eu) · Last updated 26 Oct 2026

Status (registry)
Active, not recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
55 (estimated)
First submitted
31 Jan 2025
Start date
25 Nov 2025
Lead sponsor
Boehringer Ingelheim International GmbH
EU CT number
2024-517091-38-00

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 55
  • 22 sites in 8 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (22)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Multispecialty hospital for active treatment Sveta Sofia EOOD
Coordinator of this site? Confirm its status
SofiyaBulgariaCompleted
Staedtisches Klinikum Braunschweig gGmbH
Coordinator of this site? Confirm its status
BrunswickGermanyActive, not recruiting
Universitaetsklinikum Jena KöR
Coordinator of this site? Confirm its status
JenaGermanyActive, not recruiting
Universitaet Leipzig
Coordinator of this site? Confirm its status
LeipzigGermanyActive, not recruiting
Universitaetsklinikum Ulm AoR
Coordinator of this site? Confirm its status
UlmGermanyActive, not recruiting
Hospital Universitari Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainActive, not recruiting
Centre Oscar Lambret
Coordinator of this site? Confirm its status
LilleFranceActive, not recruiting
Centre Leon Berard
Coordinator of this site? Confirm its status
LyonFranceActive, not recruiting
Centre Hospitalier Regional De Marseille
Coordinator of this site? Confirm its status
MarseilleFranceActive, not recruiting
Institut Gustave Roussy
Coordinator of this site? Confirm its status
VillejuifFranceActive, not recruiting
Semmelweis University
Coordinator of this site? Confirm its status
Budapest VIIIHungaryCompleted
Orszagos Onkologiai Intezet
Coordinator of this site? Confirm its status
Budapest XIIHungaryCompleted
Clinexpert Kft.
Coordinator of this site? Confirm its status
GyongyosHungaryCompleted
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l
Coordinator of this site? Confirm its status
MeldolaItalyCompleted
Fondazione IRCCS - Istituto Nazionale dei Tumori
Coordinator of this site? Confirm its status
MilanItalyCompleted
Azienda Ospedaliera Universitaria Federico II Di Napoli
Coordinator of this site? Confirm its status
NaplesItalyCompleted
I.F.O. Istituti Fisioterapici Ospitalieri
Coordinator of this site? Confirm its status
RomeItalyCompleted
Centro Ricerche Cliniche di Verona s.r.l.
Coordinator of this site? Confirm its status
VeronaItalyCompleted
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
Coordinator of this site? Confirm its status
GliwicePolandCompleted
Centrum Onkologii Ziemi Lubelskiej im sw Jana z Dukli
Coordinator of this site? Confirm its status
LublinPolandCompleted
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti
Coordinator of this site? Confirm its status
BucharestRomaniaActive, not recruiting
Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca
Coordinator of this site? Confirm its status
Cluj-NapocaRomaniaActive, not recruiting

This page is information, not medical advice. Discuss any trial with your doctor.